What are the ESMO guidelines concerning optimal responses to first-line treatment of chronic myelogenous leukemia (CML)?

Updated: May 23, 2021
  • Author: Emmanuel C Besa, MD; Chief Editor: Sara J Grethlein, MD, FACP  more...
  • Print
Answer

The optimal responses to first-line treatment are as follows [22] :

  • 3 months: Ph+ ≤95%, or BCR-ABL< 10%

  • 6 months: Ph+ ≤35%, or BCR-ABL < 10%

  • 12 months: Ph+ 0, or BCR-ABL ≤1%


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!